Cognivue clarity

Cognivue clarity has been studied in 4 papers since 2024: 4 observational studies in people; 2 in the past year. The newest paper, May 19, 2026: “Re: Clarifying comparative claims in digital cognitive assessment: Assessing concurrent validity in a shared cohort”.

Exposure

4 papers study it3 findingsUpdated

See all 4 papers on cognivue clarity

At a glance

The findings reach people, from one lab or study. 2 independent labs in 1 country.

“Amyloid PET SUVR ( p <.001) and pTau217 ( p <.001) levels were significantly different by Cognivue Clarity thresholds.”
Two Stage Screening for Alzheimer's Disease Clinical Trial Recrutiment Enrichment: Cognivue Clarity and Plasma pTau217AAIC 2025 abstract2025doi:10.1002/alz70856_101139

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 2 independent labs in 1 country
  • Funder: Syracuse University
  • 1 of 3 findings with company ties
  • Humans4

What is cognivue clarity linked with?

3

Studies link cognivue clarity with 3 measures: p-Tau217, amyloid PET SUVR and Repeatable Battery for the Assessment of Neuropsychological Status.

p-Tau217

mixedin humans1

1 study
  1. Cognivue clarity is associated with p-Tau217 in humans (by Cognivue Clarity thresholds) (p <.001).

    “Amyloid PET SUVR ( p <.001) and pTau217 ( p <.001) levels were significantly different by Cognivue Clarity thresholds.”

    Humansby Cognivue Clarity thresholds

    Two Stage Screening for Alzheimer's Disease Clinical Trial Recrutiment Enrichment: Cognivue Clarity and Plasma pTau217

    AAIC 2025 abstract

More on p-Tau217

Amyloid PET SUVR

mixedin humans1

1 study
  1. Cognivue clarity is associated with amyloid PET SUVR in humans (by Cognivue Clarity thresholds) (p <.001).

    “Amyloid PET SUVR ( p <.001) and pTau217 ( p <.001) levels were significantly different by Cognivue Clarity thresholds.”

    Humansby Cognivue Clarity thresholds

    Two Stage Screening for Alzheimer's Disease Clinical Trial Recrutiment Enrichment: Cognivue Clarity and Plasma pTau217

    AAIC 2025 abstract

More on Amyloid PET SUVR

Repeatable Battery for the Assessment of Neuropsychological Status

upin humans1

1 study
  1. Cognivue clarity is associated with Repeatable Battery for the Assessment of Neuropsychological Status in humans.

    “Cognivue Clarity had strong correlations with RBANS.”

    Humansn = 452

    Cognitive Assessment with Cognivue Clarity®: Psychometric Properties and Normative Ranges in a Diverse Population

    Journal of Alzheimer's disease : JAD

More on Repeatable Battery for the Assessment of Neuropsychological Status

Latest

Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 1Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 02 papers in 12 months